SNWV

#4347
SANUWAVE Health, Inc. - Common Stock
4.6 8 USD
-0.04%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
4.68
4.68
Jahresspanne
4.50
25.62
Tagesänderung
-4.31%
Monatliche Änderung
-24.15%
6 month change
-80.50%
Jahresänderung
-80.64%
Vorheriger Schlusskurs
4.6 6
Open
4.6 8
Tief
4.6 8
Hoch
4.6 8
Volumen
7
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Documents

2026

Current report, Q3 FY2026
SANUWAVE Health, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
SANUWAVE Health, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
SANUWAVE Health, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
SANUWAVE Health, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
SANUWAVE Health, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
SANUWAVE Health, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
SANUWAVE Health, Inc. current report, Q1 FY2026
8-K

SANUWAVE Health, Inc. current report, Q3 FY2024

Full document

Business Context and Reporting Period

Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 10, 2024
Reporting Period: Quarter ended June 30, 2024
Context: The Company issued a press release announcing preliminary financial results for the quarter ended June 30, 2024. This filing serves to notify the market of the release of these preliminary results.

Key Financial Metrics

The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The 8-K filing references a press release (Exhibit 99.1) containing the preliminary results but does not embed the financial data within the body of this document.

Material Changes

The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms the issuance of preliminary results for the quarter ended June 30, 2024.

Guidance, Outlook, and Risks

Management Commentary: The filing indicates that preliminary financial results were announced via a press release.
Legal Disclaimer: The information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It shall not be deemed incorporated by reference in any other filing unless expressly set forth by specific reference.
Guidance/Risks: No specific guidance, outlook, risks, contingencies, or unusual items are detailed in the text of this 8-K filing.

Investor Verification Checklist

  • Review the attached press release (Exhibit 99.1) for the actual preliminary financial figures for the quarter ended June 30, 2024.
  • Verify the specific revenue, net income, and cash flow numbers once the press release is accessed, as they are not present in the 8-K summary text.
  • Confirm whether the preliminary results include any forward-looking statements or updated guidance.
  • Check for any subsequent filings (e.g., 10-Q) that will provide audited or reviewed financial statements for the period.